SCOC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.860400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.797800E-02
Normal-vs-Stage2
5.240200E-01
Normal-vs-Stage3
8.471200E-01
Normal-vs-Stage4
5.307000E-01
Stage1-vs-Stage2
4.978000E-02
Stage1-vs-Stage3
5.100400E-02
Stage1-vs-Stage4
7.486400E-01
Stage2-vs-Stage3
3.171400E-01
Stage2-vs-Stage4
6.625400E-01
Stage3-vs-Stage4
4.075400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.913000E-01
Normal-vs-AfricanAmerican
4.312800E-01
Normal-vs-Asian
6.409200E-01
Caucasian-vs-AfricanAmerican
9.403600E-01
Caucasian-vs-Asian
6.452000E-01
AfricanAmerican-vs-Asian
6.808400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.294800E-01
Normal-vs-Female
4.327400E-01
Male-vs-Female
4.677000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.401800E-01
Normal-vs-Age(41-60Yrs)
3.033600E-01
Normal-vs-Age(61-80Yrs)
6.085200E-01
Normal-vs-Age(81-100Yrs)
4.864200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.083600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.654400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.794600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.410400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.752800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.815200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.794800E-01
Normal-vs-Daily Drinker
5.251400E-01
Normal-vs-Weekly Drinker
8.543800E-01
Normal-vs-Occasional Drinker
2.885200E-01
Normal-vs-Social Drinker
5.254200E-01
Non Drinker-vs-Daily Drinker
3.822000E-01
Non Drinker-vs-Weekly Drinker
2.607600E-01
Non Drinker-vs-Occasional Drinker
5.455900E-02
Non Drinker-vs-Social Drinker
3.980800E-01
Daily Drinker-vs-Weekly Drinker
1.357250E-01
Daily Drinker-vs-Occasional Drinker
2.081200E-01
Daily Drinker-vs-Social Drinker
8.335800E-01
Weekly Drinker-vs-Occasional Drinker
2.248200E-02
Weekly Drinker-vs-Social Drinker
1.470410E-01
Occasional Drinker-vs-Social Drinker
3.785600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.207370E-01
Normal-vs-Grade 2
1.122350E-02
Normal-vs-Grade 3
2.935700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.448400E-01
Grade 1-vs-Grade 3
5.134600E-01
Grade 1-vs-Grade 4
1.207370E-01
Grade 2-vs-Grade 3
6.381400E-01
Grade 2-vs-Grade 4
1.122350E-02
Grade 3-vs-Grade 4
2.935700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.356600E-01
Normal-vs-NonDiabetic
4.464400E-01
Diabetic-vs-NonDiabetic
1.183600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.424400E-01
Normal-vs-NoPancreatitis
5.017000E-01
Pancreatitis-vs-NoPancreatitis
6.418000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.791600E-01
Normal-vs-N1
4.956200E-01
N0-vs-N1
3.514400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.592400E-01
Normal-vs-TP53-NonMutant
4.297000E-01
TP53-Mutant-vs-TP53-NonMutant
7.190400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
